The incidence of influenza in pregnant women and the relevance of possible preventive measures

Currently, despite significant advances in the development of medicine in general, and diagnostic and therapeutic approaches in particular, the problem of influenza is still extremely relevant. Over the past years, there has been a significant decrease in the infection rate of the population. In addition, influenza in many cases has a fairly favorable course, due to passive immunization. However, this circumstance does not negate the fact that the virus can have an extremely negative impact on the human body, which significantly reduces the quality of life and predictively has negative health consequences. Also, the incidence of influenza causes negative socio-economic consequences, which are reflected in a decrease in the working capacity and, accordingly, in the labor productivity of the population, as well as in an increase in the costs of diagnosing, treating and rehabilitating the sick. In terms of considering the course of the infectious process and its likely complications, clinicians pay increased attention to patients at risk. Pregnant women require a special approach, in which, due to the presence of physiological immunosuppression, as well as anatomical and physiological features, the flu can be quite severe with the formation of a large number of complications that have negative consequences both for the health of the expectant mother and of the outcome of gestation and further development of the newborn. The goal, which was set in the article, pursues a detailed consideration of the likely complications against the background of influenza infection, as well as ways to prevent their development through vaccination. At the present stage of development of pharmacy, doctors have drugs containing weakened pathogens that can be used in pregnant women in the II and III trimester of gestation. Numerous studies have confirmed that the introduction of a quadrivalent inactivated split influenza vaccine to pregnant women does not have any negative impact on the condition of the future mother and fetus, and the protective effect of vaccination that protects pregnant women from the occurrence of severe and complicated forms of the disease can become a guarantee of maintaining the health of pregnant women and next generation.

1. Priputnevich T. V., Achkasova Ye. N., Chubarov V. V. i dr. Acute respiratory diseases and influenza in modern obstetrics: epidemiological features and diagnostic problems: a review of the literature // Epidemiologiya i vaktsinoprofilaktika. 2019; 3 (18): 89-97.

2. Karachenova A. M., Romanova Ye. N., Radnayeva S. Ts., Rinchinova D. V. Vaccinal Infections. Vaccine prophylaxis prophylaxis of influenza in pregnant women in the outpatient setting / VIII s"yezd terapevtov Zabaykal'skogo kraya. Sbornik nauchnykh trudov. Chita, 2020. P. 37-39

3. Ryzhov G. E., Turapova A. N., Ponezheva Zh. B., Romeyko V. B. Influenza in pregnant women: a clinical case // The Lechaschi Vrach Journal. 2022; 4: 44-48.

4. Avdeyeva M. G., Gafurova O. R. Highly pathogenic influenza A (H1N1) in pregnant women, the impact on birth outcomes // Epidemiologiya i infektsionnyye bolezni. 2018; 3 (23): 119-125.

5. Zenin I. V., Popov A. F., Gorelova I. S., Simakova A. I., Dmitrenko K. A. Clinical picture of influenza in pregnant women // Epidemiologiya i infektsionnyye bolezni. 2018; 1 (23): 15-22.

6. Karapetyan S. B. Influenza and pneumonia in pregnant women // Spravochnik vracha obshchey praktiki. 2019; 8: 40-56.

7. Romanovskaya A. V., Davydov A. I., Khvorostukhina N. F., Mikhaylova Ye. V., Maleyev V. V. Clinical significance of the cytokine profile in pregnant women with influenza // Infektsionnyye bolezni. 2018; 3 (16): 87-92.

8. Romanovskaya A. V., Khvorostukhina N. F., Mikhaylova Ye. V., Stepanova N. N. Risk factors and prediction of the complicated course of influenza and acute respiratory viral infections during pregnancy // Prakticheskaya meditsina. 2019; 8 (17): 74-78.

9. Briko N. I., Saltykova T. S., Gerasimov A. N. i dr. Clinical and epidemiological characteristics of influenza in 2015-2016 and 2016–2017. // Epidemiologiya i infektsionnyye bolezni. Aktual'nyye voprosy. 2017; 4 (16): 4-13.

10. Yuan S., Wen L., Zhou J. Inhibitors of influenza A virus polymerase // ACS Infect Dis. 2018; 3 (4): 218-222.

11. Posiseyeva L. V., Kuksa D. S. Prevention in obstetrics and gynecology of acute respiratory viral infections and pregnancy: prevention opportunities // Voprosy ginekologii, akusherstva i perinatologii. 2020; 6 (19): 145-152.

12. Baranov I. I., Arslanyan K. N., Nesterova L. A. Influenza in pregnant women // Akusherstvo i ginekologiya: novosti, mneniya, obucheniye. 2018; 2: 42-51.

13. Shatunova Ye. P., Linova O. I., Kalimatova D. M. Clinical and immunological aspects of the course of pregnancy and childbirth in pregnant women with influenza A (H1N1) // Prakticheskaya meditsina. 2020; 2 (18): 51-54/

14. Priputnevich T. V., Achkasova Ye. N., Chubarov V. V., Gordeyev A. B. Acute respiratory diseases and influenza in modern obstetrics: epidemiological features and diagnostic problems: a review of the literature // Epidemiologiya i vaktsinoprofilaktika. 2019; 3 (18): 89-95.

15. Klykova T. G., Prokop'yeva Ye. A. Features of the clinical course of influenza in pregnant women and analysis of the adherence of employees of obstetric institutions to vaccination of pregnant women against influenza // Infektsiya i immunitet. 2017; p: 565.

16. Kuklina L. V., Kravchenko Ye. N., Ozherel'yeva M. A., Zadorozhnaya Ye. A., Vyzhlova Ye. N., Baranov I. I. Risk factors for acute viral infections in pregnant women. The effectiveness of preventive measures // Voprosy ginekologii, akusherstva i perinatologii. 2021; 3 (20): 85-91.

17. Kalinina Z. P., Molchanovskaya M. A., Zlokazov M. D., Petrova I. G., Nechayev V. V., Gonchar N. T. Influenza incidence in pregnant women in St. Petersburg. Influence of a pregnant woman's disease on the health of a newborn // Profilakticheskaya i klinicheskaya meditsina. 2018; 3 (68): 13-19.

18. Posiseyeva L. V., Kiseleva O. Yu., Glik M. V. Fetal growth retardation: causes and risk factors // Akusherstvo i ginekologiya. Novosti. Mneniya. Obucheniye. 2021. T. 9. № 2 (32). P. 92-99.

19. Kostinov M. P., Lukachov I. V., Meshcheryakova A. K. i dr. Prevention of complications in pregnant women with mild and moderate acute respiratory infections // Epidemiologiya i Vaktsinoprofilaktika. 2018; 1 (17): 62-73.

20. Kuklina L. V., Kravchenko Ye. N., Kalygina N. Ye. Obstetric and perinatal outcomes of influenza and acute respiratory viral infections in pregnant women during the epidemic and their prevention // Dal'nevostochnyy meditsinskiy zhurnal. 2018; 3: 16-18

21. Panova I. A., Malyshkina A. I., Sotnikova N. Yu., Chasha T. V. Prevention of influenza and acute viral infections in pregnant women and newborns // Infektsionnyye bolezn: novosti, mneniya, obucheniye. 2017; 1: 3-41.

22. Romanovskaya A. V., Davydov A. I., Khvorostukhina N. F., Novichkov D. A., Trushina O. V., Stepanova N. N., Plekhanov A. A. Fetoplacental insufficiency and terms of its correction in pregnant women with influenza // Voprosy ginekologii, akusherstva i perinatologii. 2018; 3 (17): 41-44.]

23. Kudryashova O. A., Postnikova V. V., Boshkova M. E. Influence of vaccination against influenza on the course of pregnancy, fetal and newborn development // Studencheskiy vestnik. 2019; 28-2 (78): 17-19.24. SteelFisher G. K., Caporello H. L., Broussard C. S., Schafer T. J., Ben-Porath E. N., Blendon R. J. Seasonal Influenza Vaccine in Pregnant Women: Views and Experiences of Obstetrician-Gynecologists // J Womens Health (Larchmt). 2021; 8 (30): 1086-1094.